过去的十几年里溶栓疗法已成为急性心肌梗死（AMI）病人的首选疗法。通过溶栓（冠状动脉内溶栓、静脉内溶栓）、经皮腔内冠状动脉成形术（PTCA）及冠状动脉旁路移植术（CABG）等，大大提高了AMI的早期灌注率。早期人们认为对缺血心肌的再灌注可使组织得到挽救并恢复功能，但实 Thrombolytic therapy has become the preferred treatment for patients with acute myocardial infarction (AMI) over the past decade or so. The rate of early perfusion of AMI was greatly improved by thrombolytic therapy (intra-coronary thrombolysis, intravenous thrombolysis), percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG). Early thought that reperfusion of ischemic myocardium can save the tissue and restore function, but the reality